Unlock Complex Biology with Expert Flow Cytometry

NeoGenomics offers a suite of LDT-validated targeted clinical assays for hematological malignancies. These assays go beyond cells identification, delivering detailed prognostic insights into malignant cell populations.

• Highly controlled and standardized staining and acquisition procedures
• Data analysis by trained and licensed clinical laboratory scientists
• Review by board-certified hematopathologists

Leverage our deep expertise in flow cytometry across immunophenotyping receptor occupancy, cell therapy such as CAR-T, CAR-NK, CAR-NKT (cellular kinetics and dynamics), cell signaling and cell function, apoptosis, checkpoint molecules and biomarker evaluation. 
A comprehensive portfolio of validated off-the-shelf assays designed to broadly assess relevant immune subtypes or provide in-depth analysis of a specific immune subset of interest.
For unique project needs, we provide modular, fit-for-purpose custom assay development, validation, and seamless assay transfer services.

PBMC and BMMC processing services 
High-purity isolation of PBMCs and BMMCs from various sample types for subsequent analysis or cryopreservation. A range of density centrifugation and bead-based isolation methods are available to optimize both speed and cell preservation.

Cell Culture assays
Short-term cell culture assays, including:

• Cell activation and polarization assay
• Cytokine release assay